Filipe, da S., , Hughes, J., Aranday-Cortes, E., Irving, W., Foster, G., … Thomson, E. (2018). Reply to: No effect of resistance-associated substitutions in patients with rare HCV subtypes following treatment with sofosbuvir-containing regimens. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2017.11.044 (Original work published 2018)